lithium has been researched along with 6-bromoindirubin-3'-oxime in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borkan, SC; Krishnan, S; Levine, JS; Lieberthal, W; Ruchalski, KL; Schwartz, JH; Sinha, D; Wang, Z | 1 |
1 other study(ies) available for lithium and 6-bromoindirubin-3'-oxime
| Article | Year |
|---|---|
Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; Autocrine Communication; beta Catenin; Blood Proteins; Cell Line, Transformed; Cell Survival; Cytoskeletal Proteins; Genes, Reporter; Indoles; Insulin-Like Growth Factor II; Intercellular Signaling Peptides and Proteins; Kidney Tubules, Proximal; Lithium; Mice; Oximes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction; Trans-Activators; Transcription, Genetic; Wnt Proteins | 2005 |